| CTRI Number |
CTRI/2025/02/081423 [Registered on: 27/02/2025] Trial Registered Prospectively |
| Last Modified On: |
06/02/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
prospective observational study |
| Study Design |
Other |
|
Public Title of Study
|
Tracking Function in Bone Pain Patients Using Barthels Index |
|
Scientific Title of Study
|
Assessing the change in Functional status in patients with Metastatic Bone Pain using Barthels Index in Outpatient Specialist Palliative Clinic in Tertiary Cancer Hospital in India :
Prospective Observational study
|
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Raghu S Thota |
| Designation |
Professor |
| Affiliation |
TATA MEMORIAL HOSPITAL |
| Address |
Palliative Medicine OPD , Room no. 75 ,Main Building , Tata Memorial Hospital ,Dr Ernest Borges Road , Parel, Mumbai
Mumbai MAHARASHTRA 400012 India |
| Phone |
9769077764 |
| Fax |
|
| Email |
ragstho24@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Raghu S Thota |
| Designation |
Professor |
| Affiliation |
TATA MEMORIAL HOSPITAL |
| Address |
Palliative Medicine OPD , Room no. 75 ,Main Building , Tata Memorial Hospital ,Dr Ernest Borges Road , Parel, Mumbai
Mumbai MAHARASHTRA 400012 India |
| Phone |
9769077764 |
| Fax |
|
| Email |
ragstho24@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Raghu S Thota |
| Designation |
Professor |
| Affiliation |
TATA MEMORIAL HOSPITAL |
| Address |
Palliative Medicine OPD , Room no. 75 ,Main Building , Tata Memorial Hospital ,Dr Ernest Borges Road , Parel, Mumbai
Mumbai MAHARASHTRA 400012 India |
| Phone |
9769077764 |
| Fax |
|
| Email |
ragstho24@gmail.com |
|
|
Source of Monetary or Material Support
|
| Tata Memorial Hospital , Dr Ernest Borges road , Parel, Mumbai , 400012 ,Maharashtra , India |
|
|
Primary Sponsor
|
| Name |
NIL |
| Address |
NIL |
| Type of Sponsor |
Other [NIL] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 2 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Prasun P |
ACTREC |
Sector 22, Utsav Chowk - CISF Rd, Owe Camp, Kharghar, Navi Mumbai, Maharashtra 410210, India. Raigarh MAHARASHTRA |
9870450187
drprasunprem@gmail.com |
| Dr Raghu Thota |
Tata Memorial Hospital |
Room no. 75 Palliative Medicine, Ground floor, Main Building, Tata Memorial Hospital, E Borges Road, Parel Mumbai - 400012, Maharashtra, India. Mumbai MAHARASHTRA |
9769077764
ragstho24@rediffmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 2 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee - II |
Approved |
| Institutional Ethics Committee - II |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: C00-D49||Neoplasms, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
NIL |
NIL |
| Comparator Agent |
NIL |
NIL |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
80.00 Year(s) |
| Gender |
Both |
| Details |
1. Newly registered patients in Palliative Care OPD.
2. Histopathologically confirmed malignancy.
3. Advanced cancer with metastatic bone pain.
4. Communicates in English or Hindi and provides written consent. |
|
| ExclusionCriteria |
| Details |
1. Follow-up patients.
2. Unstable conditions needing emergency care.
3. Psychiatric/cognitive impairments.
4. Non-cancer-related pain.
5. Experimental/non-standard treatments. |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To assess the change in the Barthel Index score from baseline to 2 weeks in patients with metastatic bone pain receiving Palliative care. |
To assess the change in the Barthel Index score from baseline to 2 weeks in patients with metastatic bone pain receiving Palliative care. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To evaluate the change in pain intensity in patients with metastatic bone pain on palliative care |
baseline to 2 weeks |
| To evaluate change in overall QOL in patients with metastatic bone pain on palliative care |
baseline to 2 weeks |
| To document current patterns of management in patients with metastatic bone pain |
baseline to 2 weeks |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
03/03/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This prospective observational study evaluates the impact of standard palliative care on functional status in patients with metastatic bone pain using the Barthel Index. Conducted at Tata Memorial Hospital, it aims to measure changes in daily activity levels, pain intensity, and quality of life over two weeks. The study includes adults with advanced cancer and metastatic bone pain who can communicate in English or Hindi and excludes follow-up patients, those with unstable conditions, psychiatric impairments, non-cancer pain, or experimental treatments. Findings will guide improvements in palliative care for better patient outcomes. |